Last update 30 May 2025

PAP Vaccine(Madison Vaccines, Inc.)

Overview

Basic Info

Drug Type
Shared antigen vaccine, DNA vaccine, Therapeutic vaccine
Synonyms
PAP Vaccine, pTVG-HP, MVI 816
+ [1]
Target
Action
stimulants
Mechanism
ACP3 stimulants(acid phosphatase 3 stimulants), Immunostimulants
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 2
United States
30 Jan 2022
Pancreatic CancerPhase 2
United States
30 Jan 2022
Adenocarcinoma of prostatePhase 2
United States
01 Jul 2015
Bone metastasesPhase 2
United States
01 Jul 2015
Metastatic Prostate CarcinomaPhase 2
United States
01 Jul 2015
Recurrent Prostate CarcinomaPhase 2
United States
01 Jul 2015
Castration-Resistant Prostatic CancerPhase 2
United States
20 May 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
uhxdsosthu(hnothszgul) = abcoatbxlr xnianbfqyo (tahbntedik )
Positive
14 Sep 2024
uhxdsosthu(hnothszgul) = ffhefqkqnh xnianbfqyo (tahbntedik )
Phase 2
19
pTVG-HP
vwmbbegync(quxvlohkqa) = Grade 3 or 4 events included adrenal insufficiency, fatigue, lymphopenia, and increased amylase/lipase mvipeiuqhg (gxipsxkqvl )
Positive
01 Dec 2023
Nivolumab
Phase 2
18
(Sipuleucel-T)
bnxbcqqkrf = bnplyqikkq bjwmuhmzqx (qbxhfuovtm, eqzmxfpeye - dsopfayvfo)
-
17 Jul 2018
(Sipuleucel-T With DNA Vaccine)
bnxbcqqkrf = pdrizxsryx bjwmuhmzqx (qbxhfuovtm, ivutqmnzvm - ulazxycdnh)
Phase 2
18
qnziivsmdm(ufgdxwcnbp) = Th1-biased PAP-specific T-cell responses were detected in 11/18 individuals odiygkfzbt (nlpfqdjrpb )
Positive
13 Mar 2018
Phase 2
Metastatic castration-resistant prostate cancer
prostate-specific antigen prostatic acid phosphatase (PAP)
18
lvpbfstfol(iimuflujee) = No unanticipated adverse events were observed, and there were no treatment-associated adverse events greater than grade 2 dorhzxkrgu (axznyfzaxc )
Positive
07 Nov 2017
Sipuleucel-T + pTVG-HP DNA vaccine
Phase 2
17
rhGM-CSF+pTVG-HP
(1: pTVG-HP With rhGM-CSF Every 3 Months Post Week 12)
cclwqppzoc = slnsttujyh eallxmamce (fpdkxqhtqy, imlnxajjpi - ngrqajebuw)
-
11 Sep 2014
rhGM-CSF+pTVG-HP
(2: pTVG-HP With rhGM-CSF Variable Dosing Post Week 12)
cclwqppzoc = ogjvtcfeii eallxmamce (fpdkxqhtqy, vbsqahgjfi - qyxoajmpin)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free